Tag: MDMA

Canadian biotechnology company PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) has signed an agreement with Corealis Pharma Inc., a ...

The Australian psychedelic-assisted therapy provider has reported record quarterly revenue of $1.42 million, expanded its national clinic network and received ...

Canadian pharmaceutical manufacturer Optimi Health has appointed experienced pharmaceutical executive Adrian Jones to lead its Australian operations, with a focus ...

New Zealand medicinal cannabis company Rua Bioscience has signed a distribution agreement with PharmAla Biotech, following the country's first approvals ...

The three-day conference, hosted by entrepreneur Dave Asprey, brings together researchers, clinicians and business leaders to discuss psychedelic therapies, neuroscience ...

As psilocybin and MDMA move deeper into psychiatric research and clinical practice, the conversation is shifting from therapeutic promise towards ...

For much of the past decade, the modern psychedelic renaissance has been accompanied by an unusually powerful media narrative. Drugs ...

Australian psychedelic medicine company Emyria Limited (ASX: EMD) has been selected by the US Food and Drug Administration (FDA) to ...

New Zealand has authorised two psychiatrists to prescribe pharmaceutical-grade MDMA as part of supervised treatment for adults with post-traumatic stress ...

BLS Pharmaceuticals Limited (ASX: BLS) has appointed Zivana Crestani as Strategic Partnership Director, adding to the company's commercial leadership as ...